Welcome to the Official Website of Livingston Securities LLC.


ABOUT LIVINGSTON SECURITIES LLC

Livingston Securities LLC is a FINRA member investment bank/advisory and broker/dealer dedicated to providing corporate finance and strategic advisory services to corporate clients and sales, trading and related services to institutional investors and high net worth individuals who focus on nanotechnology and other emerging technologies and their impact on healthcare, energy, infrastructure and other leading sectors of the American and global economy.

Livingston Securities focuses on providing investment banking, advisory and brokerage services to a wide variety of clients, including public and private corporations, institutional and high net worth investors, governments and universities.

ABOUT OUR EXECUTIVES

Scott Livingston, Chairman and Chief Executive Officer of Livingston Securities LLC.
Mr. Livingston has been working on emerging technologies at Wall Street firms for 25 years and has specialized in nanotechnologies since 2002. Mr. Livingston has been called "sharp and highly connected" by the Forbes Wolfe Nanotechnology Report (July 1, 2005) and has been a keynote speaker on advanced technology investment trends in more than 30 states across America, including at MIT, the National Renewable Energy Lab (NREL), Brookhaven National Labs, Rice University Center for Nanotechnology, the Lawrence Berkeley Labs, Albany Nanotech, the President's National Economic Council, numerous US congressional committees. In addition, the "Livingston Nanotechnology Conference," is Wall Street's largest and longest running annual nanotechnology investor conference, now in its 10th year.

Mr. Livingston has often been called "the King of Nanotechnology on Wall Street" and Livingston Securities was founded to change the way that innovation is financed on Wall Street and to connect people with their local innovation economy.

From 2005 to 2009 Mr. Livingston was a Managing Director at Axiom Capital Management, Inc, and head of the Livingston Group, a division within Axiom focused on nanotechnology. From 2000 to 2005 Mr. Livingston was a Director in the Private Investment Management Division at Lehman Brothers. While at Lehman in 2002, Mr. Livingston began his focus on nanotechnology and started to cover the field for institutional and individual investors. From 1996 to 2000, Mr. Livingston served as a Director in the Private Client Group at Cowen & Co (later renamed SG Cowen Securities), where he was a member of the Chairman's Club from 1998 to 2000 the firm's highest honor for private client management. While at Cowen, Mr. Livingston focused on emerging technology trends, including genomics, Y2K preparedness and defense technologies. From 1993 to 1996 Mr. Livingston was a Senior Vice President in the Private Client Group at Smith Barney Inc. Mr. Livingston was named a Senior Vice President in 1993, at the age of 24, one of the youngest appointees for the firm at that time. While at Smith Barney Mr. Livingston focused on emerging technology trends, including biotechnology, data networking and telecommunications services. From 1992 to 1993 Mr. Livingston was a Vice President at Shearson Lehman Hutton, Inc. Smith Barney Inc. acquired Shearson Lehman Hutton in March of 1993. From 1989 to 1992 Mr. Livingston was an investment representative with Citigroup Global Markets.

Mr. Livingston graduated from the State University of New York at Albany with a B.A. in Political Science with a concentration in International Economic Relations. Mr. Livingston is a Board Member of the Nanobusiness Alliance and a founding Board Member of the New York Nanobusiness Alliance. Mr. Livingston is also a founding member of the Water Innovations Alliance. Mr. Livingston's registrations include Series 4, 7, 24, 27, 53, 55, 63, 65, 79 and 87.

Leonard Hagan - Financial and Operations Principal
Mr. Hagan serves as the Financial and Operations Principal of Livingston Securities. Since 1993, he has been a partner at Hagan & Burns CPA's, PC in New York. Prior to that he conducted business as a sole practitioner as well as a partner for three years at Bernstein, Bernstein & Hagan, CPAs. Mr. Hagan gained securities industry experience while he was an assistant treasurer at Credit Suisse. Prior to then he worked as the Audit Manager of Ernst & Whinney/S.D. Leidesorf. Mr. Hagan received his B.A. in Economics from Ithaca College in 1974, and earned his MBA from Cornell University in 1976. Mr. Mr. Hagan is also a director of Ridgefield Acquisition director of BKF Capital Group, Inc., a publicly traded corporation. Mr. Hagan holds licenses as a Certified Public Accountant (CPA) in New York and his Series 27.

Jeanne Rockman, Chief Compliance Officer, General Securities Principal
Ms. Rockman serves as the Chief Compliance Officer of Livingston Securities. Prior to joining Livingston Securities, she served as the Chief Compliance Officer of Schottenfeld Group, a proprietary trading and institutional sales broker-dealer in New York City. From 2002 to 2005 Ms. Rockman served as the Chief Compliance Officer for Puglisi & Co. Ms. Rockman has been engaged in the securities industry for over twenty years and has primarily been affiliated with small and mid-size firms with wide ranging business lines in the compliance and operations specialties. Ms. Rockman is the managing partner of Regulatory Consulting Services, LLC. a firm specializing in business management and compliance related consulting services to the financial industry. Ms. Rockman's registrations include Series 7, 24 and 63.

Jonathan Mason, Chief Operating Officer, General Securities Principal
Mr. Mason serves as Chief Operating Officer of Livingston Securities, overseeing senior client relationships with corporate, institutional and high-net worth clients. Prior to joining Livingston Securities, Mr. Mason served as Vice President and Head of Fixed Income for the Livingston Group, a division of Axiom Capital Management Inc. focused on nanotechnology. From 2001 to 2005, Mr. Mason was an Investment Representative at Lehman Brothers Inc. Private Investment Management. Mr. Mason graduated from Wake Forest University in Winston-Salem, NC. He is a member of the New York Chapter of Variety, The Children's Charity. Mr. Mason has spoken as an expert in nanotechnology investment to a variety of organizations and groups, including the North Carolina Nanotechnology Initiative and at the Brookhaven National Laboratory Center for Functional Nanomaterials. Mr. Mason's registrations include Series 7, 24, 55, 63 and 65.

Enrico Albano, Senior Vice President, Sales and Trading
Mr. Albano serves as a Senior Vice President, handling equity and options trading, as well as execution of employee stock options and Rule 144 stock transactions. Prior to joining Livingston Securities, Mr. Albano served as Vice President and Senior Equity Trader for the Livingston Group, a division of Axiom Capital Management Inc. Mr. Albano helped establish the Livingston Group when Lehman Brothers acquired the Private Client Group of Cowen & Co. in 2000. In 1993, he joined Cowen & Company where he became the Order Room Supervisor of one of their largest branch offices. Mr. Albano began his career in trading in 1984 working in the Bear Stearns order room. Mr. Albano's registrations include Series 7, 55 and 63.

Mostafa Analoui, Head of Healthcare
Mostafa Analoui, Ph.D., is Head of Healthcare and Life Sciences at The Livingston Group (New York, NY) and Chairman and CEO of Cense Biosciences, Inc. Previously he was the Senior Director at Pfizer Global Research and Development. He is also adjunct Professor of Oral Pathology, Medicine and Radiology at Indiana University. Dr. Analoui is actively involved in investment, management and scientific/business development of nanotechnology, drug discovery/development, diagnostic imaging, and global strategies. While at Pfizer, he was the Site Head for Global Clinical Technology in Groton and New London, a division focusing on emerging technologies for development and validation of biomarkers and diagnostics for drug development. Prior to joining Pfizer, Dr. Analoui was the Director of Oral and Maxillofacial Imaging Research, Associate Professor of Radiology at Indiana University, and Associate Professor of Biomedical Engineering and Electrical & Comp Engineering at Purdue University. He was also President and CEO of Therametric Technology Inc. He has received his Ph.D. from Purdue University, followed by Post-Doctoral Fellowship at IBM TJ Watson Research Center in NY.

In addition to industry leadership in biomedical and technology fields, he consults and lectures in US, Europe and Asia. He has also served on various scientific, regulatory, and business advisory committees and boards, including NIH, NSF, PhRMA, NASA, and OECD. Dr. Analoui has authored over 130 publications, including journal articles, book chapters, and technical reports. He is senior member of IEEE, SPIE, and RSNA. He currently serves as board member of VirtualScopics (Nasdaq: VSCP), Calando Pharmaceutical (Nasdaq: ARWR), BEACON (Biomedical Engineering Alliance and Consortium) and NanoBusiness Alliance. Dr. Analoui’s registrations include Series 7 and 63 with Livingston Securities LLC, a subsidiary of The Livingston Group.